This appears to be a routine proxy filing with no immediate trading implications. Monitor for any subsequent filings that might indicate contested items or activist involvement.
PROK drugs
PROK drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 20 $2.10entry
- T+1 · 7mo ago −0.48%α +0.18% · $2.09
- T+5 · 7mo ago −11.43%α −12.34% · $1.86
- T+20 · 6mo ago −23.33%α −27.54% · $1.61
- T+60 · 4mo ago −23.81%α −30.59% · $1.60
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
ProKidney Corp. filed a definitive proxy statement (DEFA14A) for its upcoming shareholder meeting. The filing is routine and relates to standard corporate governance matters. No activist campaign or contested vote was indicated in the available documents.
Key Facts
- Filing type is DEFA14A, a definitive proxy statement
- No activist campaign or dissident filing was indicated
- Filing appears to be routine corporate governance documentation
- No specific vote items were detailed in the provided documents
Financial Impact
No immediate financial impact expected
Risk Factors
- Limited document content available for analysis
- Potential for additional information in documents not provided
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001140361-26-015369 |
| Document: 0001140361-26-015369-index-headers.html | 0001140361-26-015369 |
| Document: 0001140361-26-015369-index.html | 0001140361-26-015369 |
| Document: 0001140361-26-015369.txt | 0001140361-26-015369 |
Track record
13 reports on PROK
5 of 5 bullish or bearish reports moved the stock their way by T+1. Best: +13.51% at T+1 after the Oct 29, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 12, 20264d ago Press Release Bearish 7/10 Entry $1.05 to $1.04 Now $1.04 +0.48% ▲ +0.48% −1.43% vs SPY
- Nov 12, 20264d ago 424B5 Bearish 6/10 Entry $1.15 to $1.05 Now $1.04 +9.57% ▲ +9.13% +8.77% vs SPY
- Nov 12, 20265d ago EFFECT Bearish 5/10 Entry $1.15 to $1.05 Now $1.04 +9.57% ▲ +9.13% +8.77% vs SPY
- Nov 9, 20267d ago 8-K Neutral 3/10 Entry $1.15 to $1.11 Now $1.04 −9.57% ▼ −3.48% −3.11% vs SPY
- Oct 29, 202618d ago 8-K Bearish 6/10 Entry $1.30 to $1.12 Now $1.04 +19.69% ▲ +13.51% +13.03% vs SPY
- Oct 29, 202618d ago S-3 Bearish 6/10 Entry $1.30 to $1.12 Now $1.04 +19.69% ▲ +13.51% +13.03% vs SPY
- Oct 22, 202625d ago Press Release Neutral 3/10 Entry $1.43 to $1.41 Now $1.04 −27.27% ▼ −1.40% −0.88% vs SPY
- Aug 10, 202614w ago 8-K Neutral 5/10 No price data
- Aug 10, 202614w ago Press Release Neutral 5/10 Entry $1.61 to $1.48 Now $1.04 −35.40% ▼ −8.07% −8.32% vs SPY
- May 15, 202626w ago 8-K Neutral 4/10 No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers